Prenatal diagnosis of the fragile X syndrome: Possible end of the experimental phase for amniotic fluid
Lawrence R. Shapiro, Patricia D. Murphy(Newark Beth Israel Medical Center), Patrick L. Wilmot(Westchester Medical Center)
Cited by 8
Related Papers
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
|PubMed|1989|963
Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy
|New England Journal of Medicine|2000|726
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
|Genetics in Medicine|2015|292
Genetic Information and the Workplace: Legislative Approaches and Policy Challenges
|Science|1997|153
Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability
|PLoS Pathogens|2016|78